Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | No |
| Is net profit margin increasing? | Yes | No |
| Is asset turnover increasing? | No | No |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| ALK-Abelló A/S |
| DanCann Pharma A/S |
| Stenocare A/S |
| Pharma Equity Group A/S |
| H. Lundbeck A/S |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| ALK B | DANCAN | STENO | PEG | HLUN A | CESSA | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 17% | -69% | -309% | NA | 13% | -462% | ||
| Fiscal Year - 1 | 12% | -172% | -70% | NA | 11% | NA | ||
| Fiscal Year - 2 | 9% | -28% | -51% | NA | 10% | NA | ||
| Fiscal Year - 3 | 7% | -24% | -27% | NA | 7% | NA | ||
| Fiscal Year - 4 | 1% | NA | -36% | NA | 9% | NA | ||
| Fiscal Year - 5 | -2% | 80% | 10% | NA | 15% | NA | ||
| Average | 7% | -43% | -80% | NA | 11% | -462% | ||
| Median | 8% | -28% | -43% | NA | 10% | -462% | ||
| Benchmarks | Ticker | |||||||
| ALK-Abelló A/S | CPSE:ALKB | |||||||
| DanCann Pharma A/S | NGM:DANCAN | |||||||
| Stenocare A/S | CPSE:STENO | |||||||
| Pharma Equity Group A/S | CPSE:PEG | |||||||
| H. Lundbeck A/S | CPSE:HLUNA | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | ALK B | DANCAN | STENO | PEG | HLUN A | CESSA | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 5,537 | 8 | 2 | NA | 22,004 | 2 | ||
| Fiscal Year | 5,537 | 8 | 2 | NA | 22,004 | 2 | ||
| Fiscal Year - 1 | 4,824 | 7 | 4 | NA | 19,912 | NA | ||
| Fiscal Year - 2 | 4,511 | 7 | 4 | NA | 18,246 | NA | ||
| Fiscal Year - 3 | 3,916 | 2 | 2 | NA | 16,299 | NA | ||
| Fiscal Year - 4 | 3,491 | NA | 0 | NA | 17,672 | NA | ||
| Fiscal Year - 5 | 3,274 | (0) | 5 | NA | 17,036 | NA | ||
| Net Income | ||||||||
| Latest Twelve Months | 815 | (8) | (34) | (24) | 3,143 | (15) | ||
| Fiscal Year | 815 | (8) | (34) | (24) | 3,143 | (15) | ||
| Fiscal Year - 1 | 486 | (62) | (18) | (24) | 2,290 | (27) | ||
| Fiscal Year - 2 | 335 | (16) | (16) | (9) | 1,916 | (15) | ||
| Fiscal Year - 3 | 219 | (12) | (13) | NA | 1,318 | (12) | ||
| Fiscal Year - 4 | 25 | (4) | (12) | NA | 1,581 | (1) | ||
| Fiscal Year - 5 | (50) | (0) | 2 | NA | 2,313 | NA | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 6,726 | 17 | 38 | 68 | 37,407 | 9 | ||
| Latest Fiscal Quarter | 8,246 | 15 | 20 | 66 | 56,976 | 16 | ||
| Fiscal Year | 8,246 | 15 | 20 | 66 | 56,976 | 16 | ||
| Fiscal Year - 1 | 6,726 | 17 | 38 | 68 | 37,407 | 9 | ||
| Fiscal Year - 2 | 6,308 | 74 | 40 | 22 | 37,452 | 28 | ||
| Fiscal Year - 3 | 5,830 | 69 | 44 | NA | 34,653 | 31 | ||
| Fiscal Year - 4 | 5,563 | 50 | 56 | NA | 36,029 | 14 | ||
| Fiscal Year - 5 | 5,495 | 1 | 32 | NA | 38,133 | NA | ||
| Fiscal Year - 6 | 4,865 | NA | 22 | NA | 23,011 | NA | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 4,447 | 10 | 26 | 25 | 22,045 | (2) | ||
| Latest Fiscal Quarter | 5,373 | 14 | (3) | 49 | 25,010 | 8 | ||
| Fiscal Year | 5,373 | 14 | (3) | 49 | 25,010 | 8 | ||
| Fiscal Year - 1 | 4,447 | 10 | 26 | 25 | 22,045 | (2) | ||
| Fiscal Year - 2 | 3,988 | 63 | 24 | 19 | 20,779 | 24 | ||
| Fiscal Year - 3 | 3,480 | 53 | 40 | NA | 18,279 | 26 | ||
| Fiscal Year - 4 | 3,153 | 44 | 53 | NA | 16,973 | 14 | ||
| Fiscal Year - 5 | 3,176 | (1) | 13 | NA | 16,782 | NA | ||
| Fiscal Year - 6 | 3,179 | NA | 20 | NA | 14,251 | NA | ||